Scotiabank Boosts Amgen Stock Price Target to $500
Amgen's stock price target has been raised to $500 by Scotiabank. This increased prediction comes after the bank revised its initial forecast of $450.
The adjustment reflects Scotiabank's updated assessment of Amgen's financial performance and market prospects.